EP1907589A4 - UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE - Google Patents

UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE

Info

Publication number
EP1907589A4
EP1907589A4 EP06788815A EP06788815A EP1907589A4 EP 1907589 A4 EP1907589 A4 EP 1907589A4 EP 06788815 A EP06788815 A EP 06788815A EP 06788815 A EP06788815 A EP 06788815A EP 1907589 A4 EP1907589 A4 EP 1907589A4
Authority
EP
European Patent Office
Prior art keywords
susceptibility
relation
cardiovascular disease
nucleotide polymorphisms
unique nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06788815A
Other languages
German (de)
French (fr)
Other versions
EP1907589A2 (en
Inventor
Monika Stoll
Gerd Assmann
Helmut Schulte
Werner Kroll
Stephen Schwers
Christoph Petry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Priority to EP06788815A priority Critical patent/EP1907589A4/en
Publication of EP1907589A2 publication Critical patent/EP1907589A2/en
Publication of EP1907589A4 publication Critical patent/EP1907589A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP06788815A 2005-07-26 2006-07-26 UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE Withdrawn EP1907589A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06788815A EP1907589A4 (en) 2005-07-26 2006-07-26 UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US70276005P 2005-07-26 2005-07-26
US70321905P 2005-07-27 2005-07-27
US70871905P 2005-08-15 2005-08-15
US74240705P 2005-12-05 2005-12-05
EP06012722 2006-06-21
PCT/US2006/029449 WO2007014338A2 (en) 2005-07-26 2006-07-26 Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease
EP06788815A EP1907589A4 (en) 2005-07-26 2006-07-26 UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE

Publications (2)

Publication Number Publication Date
EP1907589A2 EP1907589A2 (en) 2008-04-09
EP1907589A4 true EP1907589A4 (en) 2010-11-24

Family

ID=37683999

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06788815A Withdrawn EP1907589A4 (en) 2005-07-26 2006-07-26 UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE

Country Status (2)

Country Link
EP (1) EP1907589A4 (en)
WO (1) WO2007014338A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2267153A1 (en) * 2009-05-26 2010-12-29 Université Claude Bernard Lyon 1 Identification of netrin-1 receptor unc5c gene mutation in solid cancers
EP4729636A2 (en) * 2020-03-16 2026-04-22 The University of North Carolina at Chapel Hill Compositions and methods for the selective detection of tumor-derived viral dna

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001055163A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6342357B1 (en) * 1999-08-09 2002-01-29 University Of Utah Research Foundation Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
WO2004035746A2 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2702148C (en) * 1999-01-06 2014-03-04 Genenews Inc. Method of profiling gene expression in a human subject having an infectious disease
WO2001079561A2 (en) * 2000-04-17 2001-10-25 Liggett Stephen B Alpha-2 adrenergic receptor polymorphisms
WO2004058052A2 (en) * 2002-12-20 2004-07-15 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342357B1 (en) * 1999-08-09 2002-01-29 University Of Utah Research Foundation Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
WO2001055163A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2004035746A2 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIROV GEORGE ET AL: "Pooled DNA genotyping on Affymetrix SNP genotyping arrays.", BMC GENOMICS 2006 LNKD- PUBMED:16480507, vol. 7, 27, 15 February 2006 (2006-02-15), XP002600319, ISSN: 1471-2164 *

Also Published As

Publication number Publication date
EP1907589A2 (en) 2008-04-09
WO2007014338A3 (en) 2010-05-20
WO2007014338A8 (en) 2007-04-12
WO2007014338A2 (en) 2007-02-01

Similar Documents

Publication Publication Date Title
EP1943264A4 (en) OLIGONUCLEOTIDE ANALOGUES INCORPORATING 5-AZACYTOSINE IN THESE
EP1968612A4 (en) NUCLEOTIDE AND OLIGONUCLEOTIDE PROMEDICAMENTS
ZA200805141B (en) Improved targeted nucleotide exchange with propynyl modified oligonucleotides
IL202530A0 (en) Targeted nucleotide exchange with improved modified oligonucleotides
ZA201003235B (en) Use of oligonucleotides with modified bases in hybridization of nucleic acids
GB0517097D0 (en) Modified nucleosides and nucleotides and uses thereof
NL2000184A1 (en) Bicycle with suspension.
DE602007006615D1 (en) Bicycle rear derailleur
BRPI0718796A2 (en) NUCLEOTIDE
EP1827460A4 (en) NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
DK2735568T3 (en) OLIGONUCLEOTIDE ANALYSIS WITH CATIONIC BINDINGS BETWEEN SUB-UNITS
EP1963536A4 (en) POLYMERASES FOR INCORPORATING NUCLEOTIDE ANALOGS
BRPI0808014A2 (en) TRANSGLUTAMINASE VARIANTS WITH IMPROVED SPECIFICITY
EP1937702A4 (en) Labeled nucleotide analogs and uses therefor
ITRM20050115U1 (en) BICYCLE CHASSIS CONFIGURED TO HIDE THE SHIFT WIRE.
DE602007005559D1 (en) Bicycle derailleur
DE602005015779D1 (en) Bicycle computer and handlebar assembly with cycle computer
DK1765844T3 (en) Purine nucleotide derivatives
BRPI0911104A2 (en) single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
EP1907589A4 (en) UNIQUE NUCLEOTIDE POLYMORPHISMS WITH SUSCEPTIBILITY IN RELATION TO CARDIOVASCULAR DISEASE
DE602006009319D1 (en) bicycle handlebars
FR2908133B1 (en) NOVEL NUCLEOTIDE ANALOGUES AS ANTIVIRAL PRECURSOR MOLECULES
ITMI20062262A1 (en) SADDLE STRUCTURE FOR BICYCLE
GB0616215D0 (en) Itpase gene polymorphisms associated with adverse drug reactions to azathioprine
FR2887826B1 (en) SEAT FIT TO BE MOUNTED ON A SUPPORT STRUCTURE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080128

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: PETRY, CHRISTOPH

Inventor name: SCHWERS, STEPHEN

Inventor name: KROLL, WERNER

Inventor name: SCHULTE, HELMUT

Inventor name: ASSMANN, GERD

Inventor name: STOLL, MONIKA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC.

R17D Deferred search report published (corrected)

Effective date: 20100520

A4 Supplementary search report drawn up and despatched

Effective date: 20101021

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110201